TL 177 Pill: Cyclobenzaprine HCl 10mg — Identification, Uses, and Safety

A small yellow round pill with the imprint "TL 177" is a tablet of cyclobenzaprine hydrochloride, one of the most commonly prescribed muscle relaxants in the United States. Cyclobenzaprine goes by the brand name Flexeril and is typically prescribed alongside rest and physical therapy for short-term management of the pain and discomfort associated with acute, painful musculoskeletal conditions. It is among the top 50 most prescribed drugs in the US by volume, yet many patients don't fully understand what it is, how it works, or its notable limitations and side effects.

Pill Identification

Trigen Laboratories is a generic pharmaceutical manufacturer operating in the United States. The "TL" prefix is their standard imprint designation. The TL 177 tablet is a generic version of cyclobenzaprine HCl 10mg — the standard adult strength — and is a small, round, yellow tablet. Cyclobenzaprine is also available in 5mg immediate-release tablets and 15mg and 30mg extended-release capsules, but the 10mg immediate-release tablet is the most frequently prescribed formulation.

The brand name Flexeril was historically the dominant name for cyclobenzaprine but is now less commonly seen as generic versions have largely replaced the branded product. The drug has been available since its FDA approval in 1977 and has decades of clinical use history.

What Cyclobenzaprine Is Used For

Cyclobenzaprine is a skeletal muscle relaxant. Despite its structural similarity to tricyclic antidepressants (a class of older antidepressants), it is not used to treat depression. Its muscle-relaxing effects are thought to operate primarily in the central nervous system — specifically in the brainstem — rather than directly at the muscle itself. By acting on the CNS, it reduces the hyperactivity of motor neurons that contributes to muscle spasm.

It is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. The key word is "acute" — cyclobenzaprine is intended for short-term use, typically two to three weeks. It has not been found to be effective for long-term use, and evidence of benefit beyond three weeks is lacking. It is not approved for spasticity associated with neurological conditions such as cerebral palsy or multiple sclerosis.

Common conditions for which it may be prescribed include acute low back pain, neck pain, sprains, and strains where muscle spasm is a significant component. It is typically used alongside, not instead of, other treatments such as physical therapy, heat, and appropriate activity modification.

Important Safety Information

Sedation

The most common side effect of cyclobenzaprine is significant drowsiness, which occurs in a substantial portion of patients. This is not a minor inconvenience — cyclobenzaprine can meaningfully impair driving ability, reaction time, and cognitive function. Patients should not drive, operate heavy machinery, or engage in activities requiring alertness until they know how the drug affects them. Sedation is compounded by alcohol, benzodiazepines, opioids, antihistamines, and other CNS depressants.

Anticholinergic Effects

Because of its tricyclic-related structure, cyclobenzaprine has anticholinergic properties. Side effects can include dry mouth, blurred vision, urinary retention, and constipation. These effects can be troublesome, particularly in older adults who may already be taking other medications with anticholinergic activity. The cumulative anticholinergic burden in elderly patients is a recognized clinical concern that prescribers should consider.

Serotonin Syndrome Risk

Cyclobenzaprine inhibits serotonin reuptake and can contribute to serotonin syndrome when combined with other serotonergic agents, including SSRIs, SNRIs, tramadol, MAO inhibitors, and triptans. Patients on any of these medications should discuss this interaction with their prescriber before starting cyclobenzaprine.

Frequently Asked Questions

Is cyclobenzaprine a controlled substance?

Cyclobenzaprine is not classified as a controlled substance under the Controlled Substances Act. However, it does have potential for misuse due to its sedating effects, and some states have begun tracking its prescribing. It requires a prescription from a licensed prescriber.

How long does cyclobenzaprine stay in your system?

Cyclobenzaprine has a relatively long half-life of approximately 18 hours, meaning it takes multiple days for the drug to fully clear the body. Its effects on alertness and coordination can persist well beyond the time the tablet was taken, which is important to account for when driving or working. Standard urine drug screens may detect cyclobenzaprine for several days after the last dose.

Can I take cyclobenzaprine with ibuprofen?

Combining cyclobenzaprine with ibuprofen or other NSAIDs is commonly done for musculoskeletal pain management, as the two drugs address different aspects of pain (muscle spasm vs. inflammation). However, this and all medication combinations should be reviewed by a prescriber or pharmacist to ensure there are no contraindications in the context of an individual patient's full medication list and health conditions.

Why is cyclobenzaprine only recommended short-term?

Clinical trials supporting cyclobenzaprine's efficacy were primarily conducted over short periods, and evidence of benefit beyond two to three weeks is lacking. The drug is intended as a short-term bridge while an acute musculoskeletal injury heals with rest and physical therapy — not as a long-term solution for chronic pain. Long-term use raises concerns about continued sedation, anticholinergic side effects, and the absence of evidence of sustained benefit.